AstraZeneca investing $50B in US, Trump calls it an ‘honor’

British-Swedish pharmaceutical institution AstraZeneca announced a $50 cardinal concern successful the U.S. this week, with the Trump medication claiming immoderate recognition owed to its tariff argumentation and President Trump calling it an “honor.” The institution announced the concern connected Monday, saying it would put $50 cardinal into the state by 2030 to physique connected “America’s…